These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9240596)
1. The differential expression of the HER-2/neu oncogene among high-risk human papillomavirus-infected glandular lesions of the uterine cervix. Roland PY; Stoler MH; Broker TR; Chow LT Am J Obstet Gynecol; 1997 Jul; 177(1):133-8. PubMed ID: 9240596 [TBL] [Abstract][Full Text] [Related]
2. Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papilloma virus types in preinvasive cervical lesions. Mourón SA; Abba MC; Güerci A; Gómez MA; Dulout FN; Golijow CD Mutat Res; 2000 Aug; 469(1):127-34. PubMed ID: 10946249 [TBL] [Abstract][Full Text] [Related]
3. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923 [TBL] [Abstract][Full Text] [Related]
4. Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization. Sheng Z; Minato H; Sasagawa T; Nakada S; Kinoshita E; Kurose N; Nojima T; Makinoda S Int J Clin Exp Pathol; 2013; 6(10):2168-77. PubMed ID: 24133595 [TBL] [Abstract][Full Text] [Related]
5. SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma. Hopman ANH; Moshi JM; Hoogduin KJ; Ummelen M; Henfling MER; van Engeland M; Wouters KAD; Stoop H; Looijenga LHJ; Ramaekers FCS Histopathology; 2020 Feb; 76(3):383-393. PubMed ID: 31444787 [TBL] [Abstract][Full Text] [Related]
6. [High-risk human papillomavirus DNA testing and histologic follow up in women with abnormal cytology]. Zhao CQ; Yang HT; Xue DB; Yang M Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):774-8. PubMed ID: 23302344 [No Abstract] [Full Text] [Related]
7. [Morphology of lesions of the uterine cervix and human papillomaviruses]. Meisels A; Morin C Arch Anat Cytol Pathol; 1997; 45(5):261-7. PubMed ID: 9588036 [No Abstract] [Full Text] [Related]
8. Correspondence re: Ferguson AM, Svoboda-Newman SM, Frank TS: Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 1:11-18, 1998. Tenti P; Zappatore R; Carnevali L Mod Pathol; 1999 Dec; 12(12):1192-3. PubMed ID: 10619275 [No Abstract] [Full Text] [Related]
9. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study. Kawauchi S; Kusuda T; Liu XP; Suehiro Y; Kaku T; Mikami Y; Takeshita M; Nakao M; Chochi Y; Sasaki K Am J Surg Pathol; 2008 Dec; 32(12):1807-15. PubMed ID: 18779726 [TBL] [Abstract][Full Text] [Related]
10. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386 [TBL] [Abstract][Full Text] [Related]
11. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix. Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239 [TBL] [Abstract][Full Text] [Related]
12. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656 [TBL] [Abstract][Full Text] [Related]
13. Overexpression/amplification of HER-2/neu is uncommon in invasive carcinoma of the uterine cervix. Rosty C; Couturier J; Vincent-Salomon A; Genin P; Fréneaux P; Sigal-Zafrani B; Sastre-Garau X Int J Gynecol Pathol; 2004 Jan; 23(1):13-7. PubMed ID: 14668544 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix. Tervahauta A; Syrjänen S; Syrjänen K Int J Gynecol Pathol; 1994 Jul; 13(3):234-40. PubMed ID: 7928056 [TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of P16INK4A and PTEN in high-risk human papillomavirus-related cervical cancer]. Zhao XL; Cheng SX; Kong XD Ai Zheng; 2007 May; 26(5):480-3. PubMed ID: 17672936 [TBL] [Abstract][Full Text] [Related]
16. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Jaworski RC Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126 [TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Farnsworth A; Laverty C; Stoler MH Int J Gynecol Pathol; 1989; 8(4):321-30. PubMed ID: 2553629 [TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations. Skyldberg BM; Murray E; Lambkin H; Kelehan P; Auer GU Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271 [TBL] [Abstract][Full Text] [Related]
19. Histogenesis of cervical adenocarcinoma with reference to human papillomavirus-18 as a carcinogen. Okagaki T; Tase T; Twiggs LB; Carson LF J Reprod Med; 1989 Sep; 34(9):639-44. PubMed ID: 2553963 [TBL] [Abstract][Full Text] [Related]
20. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection. Nair P; Nair KM; Jayaprakash PG; Pillai MR Pathol Oncol Res; 1999; 5(2):95-103. PubMed ID: 10393359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]